RXO ($RXO) posted quarterly earnings results for Q2 2026 on Thursday, August 6th. The company reported earnings of $0.06 per share, beating estimates of $0.03 by $0.03. The company also reported revenue of $1,774,000,000, beating estimates of $1,617,871,893 by $156,128,107.
You can see Quiver Quantitative's $RXO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
RXO Insider Trading Activity
RXO insiders have traded $RXO stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $RXO stock by insiders over the last 6 months:
- PARTNERS, LP MFN purchased 532,276 shares for an estimated $6,387,312
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
RXO Hedge Fund Activity
We have seen 136 institutional investors add shares of RXO stock to their portfolio, and 114 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 4,711,584 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $68,883,358
- HOOD RIVER CAPITAL MANAGEMENT LLC added 2,458,725 shares (+123.3%) to their portfolio in Q1 2026, for an estimated $35,946,559
- ORBIS ALLAN GRAY LTD added 1,720,219 shares (+5.0%) to their portfolio in Q1 2026, for an estimated $25,149,601
- FRONTIER CAPITAL MANAGEMENT CO LLC added 1,090,466 shares (+69.9%) to their portfolio in Q1 2026, for an estimated $15,942,612
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,005,075 shares (-94.8%) from their portfolio in Q2 2026, for an estimated $27,730,019
- KENNEDY CAPITAL MANAGEMENT LLC added 976,475 shares (+135.7%) to their portfolio in Q1 2026, for an estimated $14,276,064
- MORGAN STANLEY removed 962,783 shares (-43.5%) from their portfolio in Q1 2026, for an estimated $14,075,887
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
RXO Analyst Ratings
Wall Street analysts have issued reports on $RXO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 05/15/2026
To track analyst ratings and price targets for RXO, check out Quiver Quantitative's $RXO forecast page.
RXO Price Targets
Multiple analysts have issued price targets for $RXO recently. We have seen 9 analysts offer price targets for $RXO in the last 6 months, with a median target of $22.0.
Here are some recent targets:
- Ariel Rosa from Citigroup set a target price of $30.0 on 07/09/2026
- Thomas Wadewitz from UBS set a target price of $26.0 on 06/30/2026
- Brandon Oglenski from Barclays set a target price of $28.0 on 06/26/2026
- J. Bruce Chan from Stifel set a target price of $22.0 on 05/15/2026
- Ravi Shanker from Morgan Stanley set a target price of $22.0 on 05/08/2026
- Christian Wetherbee from Wells Fargo set a target price of $22.0 on 05/08/2026
- Bascome Majors from Susquehanna set a target price of $18.0 on 05/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
